Download Med-Instill Inc - Medical Instill Technologies, Inc

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
NESTLE CONTACT: T. Schweizer
+41 21 924 3076
MEDINSTILL: Andrea Calise
Kekst and Company
212-521-4845
For Immediate Release
Nestlé Nutrition and Medical Instill Technologies, Inc. Announce Exclusive
Partnership Agreement to Manufacture Sterile Liquid Nutrition Products
-- Utilization of MedInstill’s Pioneering Innovation Signals Breakthrough in
Pharmaceutical, Food and Cosmetic Safety --- Nestlé deal follows MedInstill’s transaction with GlaxoSmithKline for vaccines
and injectable pharmaceuticals -New Milford, Connecticut, May 16, 2005 – Nestlé Nutrition, a unit of Nestlé
S.A. the world’s biggest food and beverage company, and Medical Instill
Technologies, Inc. (MedInstill), a U.S.-based technology company, today
announced a major partnership agreement to use MedInstill’s “Intact”™
technology to develop and manufacture sterile liquid nutrition products.
Under the agreement and in exchange for certain payments and royalties,
MedInstill grants an exclusive license to Nestlé to use MedInstill’s:
• Ground breaking, patented “Intact”™ products for the sterile filling of liquid
nutrition products
• One-way barrier "Puredose"TM valve technology that allows multiple dose
preservative-free delivery of liquid nutrition products without risk of
contamination
As part of the agreement, MedInstill, which is currently located in Stamford, will
relocate to a facility owned by Nestlé in New Milford, Connecticut where it will
develop pilot production capabilities for its nutrition, pharmaceutical and cosmetic
applications.
Dr. Daniel Py, Chairman of MedInstill, said, “We are excited to be forging this
important partnership with Nestlé, which will bring MedInstill into the nutrition
market and provide us important resources that will enable us to accelerate and
expand our development."
“The primary objective of MedInstill is to pioneer breakthrough technologies that
have the potential to change how medicines, food and topical products are
manufactured and delivered, improving their safety profile. Vaccines and liquid
nutrients are used widely in children and the opportunity to modestly contribute to
improving children’s health has been a motivating and rewarding goal of the
company.”
Using MedInstill’s patented “Intact”™ processes, closed containers are filled
through a stopper with a needle and re-sealed with a laser. This new and
innovative filling method ensures the sterility of liquid and semi-solid products. By
dramatically simplifying the sterile filling process, this new approach provides a
high safety level at lower capital and operating costs.
The “Puredose”™ valve has been proven to allow the delivery of liquids, creams
and gels without contamination of the package throughout the life of the product,
resulting in the elimination of preservatives. Preservatives are known to cause
adverse reactions to some people.
In October 2004, MedInstill entered into a similar license agreement with
GlaxoSmithKline for vaccines and other injectable pharmaceuticals, which may
have important long-term benefits for safety, availability and cost in vaccine
production.
MedInstill is currently pursuing similar partnerships in the ophthalmology,
dermatology and cosmetic fields.
MedInstill, advised by the New York office of Rothschild, and legal counsel
McCarter & English LLP, is actively involved in the development, production and
commercialization of other delivery devices.
About Med-Instill
Medical Instill Technologies (http://www.medinstill.com) is a company dedicated
to the invention, development and commercialization of technologies for the
aseptic manufacturing and delivery of pharmaceutical, cosmetic and nutrition
products. MedInstill has filed over 200 patents for the aseptic filling and multiple
dose delivery of preservative-free products. In addition, MedInstill's devices are
conceived for enhancing drug efficacy and reducing side effects through
accurate, consumer friendly, metered dose delivery systems for topical
applications on skin and mucous membranes.
About Nestlé Nutrition
Nestlé Nutrition is an autonomous business operation within the Nestlé group
that will manage and develop, as of 1 January 2006, the group's core nutrition
business. Through science-based nutrition products and services, Nestlé
Nutrition will help enhance the quality of people’s lives by supporting health and
providing care for specific consumer groups with special nutrition needs at every
stage of life. Its product portfolio – covering infant nutrition, healthcare nutrition
and performance nutrition – includes such trusted and well-recognised brands
as: NAN, LACTOGEN, NESLAC, NUTREN, PEPTAMEN and POWERBAR.